News About: Pharm. Industry
“Pharmaceutical industry is people’s industry, presidential innovative committee for the industry must be installed”
“Pharmaceutical industry is the people’s industry. In order to strengthen capability as a ‘future food’ industry, the pharmaceutical industry desperately supports from the government. I will request installation of th...
KPMA confirmed to change the name to Korea Pharmaceutical and Bio-Pharma Manufacturers Association
The new name of the Korea Pharmaceutical Manufacturers Association(KPMA) got confirmed as the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA).
The association announced that the Ministry of Healt...
Pharmas start to turn high sellers to their own online malls
There are concerns that online shopping malls operated by pharmaceutical company might weaken the function of pharmaceutical distribution companies.
According to the distribution industry, it was argued some pharmace...
Listed pharmas own KRW 1.8 trillion cashable assets
It was calculated listed pharmaceutical companies have approximately KRW 1.8 trillion cashable assets.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed pharmaceutical compan...
“CSO has no responsibility to make income & expenditure reports”
The Ministry of Health and Welfare(MOHW) gave an interpretation that a CSO does not need to make income & expenditure reports under the current law.
Deputy Director Jae-Woo Park at the MOHW Pharmaceutical Policy Divi...
Dongkook starts to sell worldwide scar treatment ‘CICA-CARE’ at pharmacies
Dongkook Pharmaceutical signed an agreement of the scar treatment ‘CICA-CARE’ 12X3cm with the global healthcare company ‘Smith&Nephew’ and started to sell it at pharmacies.
CICA-CARE, made 100% with medical silicone,...
Kim&Chang recruits Kyung-Ho Lee, former KPMA chairman, as senior advisor
Kyung-Ho Lee, the former chairman of the Korea Pharmaceutical Manufacturers Association(KPMA), will start to work as a senior advisor at Kim & Chang from the 20th of March.
After having a service as the chairman for ...
Listed pharmas focusing on reducing SG&A expenses for high profitability
In order to raise profitability, listed pharmaceutical companies are focusing on reducing SG&A(selling, general & administrative) expenses.
It was criticized, however, the top pharmaceutical companies have been weake...
Listed pharmas weakened even in manufacturing-level profitability
It was analyzed the listed pharmaceutical companies’ gross margin/sales ratio is getting weaker and weaker in not only sales, but manufacturing-level profitability.
According to the Yakup Shinmoon’s(www.yakup.com) an...
‘Chemical’ vs ‘Biotechnology’ innovative pharmas in operating performance
In terms of the innovative pharmaceutical companies’ operating performance last year, chemical and biotechnology companies showed the opposite outcomes.
While pharmaceutical companies focusing on chemical drugs recor...
